Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score

【24h】

Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score

机译：在T1-2，N0-1 ER阳性/ HER2阴性乳腺癌患者中的应用在患者中的应用：生存分析与临床风险分数

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词
breast neoplasm; adjuvant treatment; 21-gene recurrence score; chemotherapy;

机译：乳腺肿瘤;佐剂治疗;21-基因复发得分;化疗;

相似文献

外文文献
中文文献
专利

1. Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：在T1-2，N0-1 ER阳性/ HER2阴性乳腺癌患者中的应用在患者中的应用：生存分析与临床风险分数
2. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer [J] . Wen-Wen Zhang, Qin Tong, Jia-Yuan Sun, Frontiers in Oncology . 2019,第2016期

机译：21基因复发评分分析无法预测T1-2 N1mic ER阳性HER2阴性乳腺癌的乳房切除术后放疗的益处
3. Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10) [J] . Bernhard C. Pestalozzi, Christoph Tausch, Konstantin J. Dedes, BMC Cancer . 2017,第1期

机译：瑞士肿瘤委员会采用21基因复发评分（ERK 26/10）为ER阳性/ HER2阴性的早期乳腺癌患者提供辅助治疗建议
4. Survival Analysis of Colorectal Cancer Patients with Tumor Recurrence Using Global Score Test Methodology [C] . Zakiyah Zain, Nazrina Aziz, Yuhaniz Ahmad, International Conference on Quantitative Sciences and Its Applications . 2014

机译：使用全球评分试验方法肿瘤复发性结直肠癌患者的存活分析
5. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
6. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer [O] . Wen-Wen Zhang, Qin Tong, Jia-Yuan Sun, 2007

机译：21基因复发评分分析无法预测T1-2 N1mic ER阳性HER2阴性乳腺癌的乳房切除术后放疗的益处
7. A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores [O] . Takeo Fujii, Hiroko Masuda, Yee Chung Cheng, 2021

机译：A 95基因签名分层侵袭性疾病的复发风险，具有中间体21-基因签名复发评分

Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score

著录项

相似文献

相关主题

期刊订阅